MARATTO

article · Food Chemistry Advances

Biological and bioactive components of bitter leaf (Vernonia amygdalina leaf): Insight on health and nutritional benefits. A review

202351 citationsOpen accessDelta State University

In plain language

Bitter leaf, scientifically known as Vernonia amygdalina, contains a diverse profile of bioactive phytochemicals linked to disease prevention and treatment. Chemical assessments identify compounds such as alkaloids, flavonoids, phenolic acids, tannins, steroids, saponins, lignans, xanthones, anthraquinones, oxalate, and cyanogenic glycosides within the leaf. These constituents underpin several documented medicinal properties, notably antioxidant activity, anticancer capabilities, and cholesterol-lowering effects, alongside potential utility as a natural remedy for diabetes. Scientific evidence also supports the broader role of plant extracts in addressing bacterial, protozoal, and helminthic illnesses linked to inflammatory and oxidative mechanisms. Beyond targeted therapeutic properties, the regular consumption of bitter leaf juice is noted for its positive contributions towards general human health and wellness.

Key takeaways

  • Bitter leaf contains numerous phytochemicals, including alkaloids, flavonoids, tannins, saponins, and phenolic acids.
  • Bioactive extracts from the plant demonstrate antioxidant, anticancer, and cholesterol-lowering activities.
  • The plant shows clear potential as a natural remedy for diabetes management.
  • Consumption of bitter leaf juice provides beneficial contributions to general health and wellness.

Why it matters

Chronic conditions driven by inflammation and oxidative stress remain widespread public health challenges. Clarifying the biological constituents of widely available medicinal plants like bitter leaf provides a scientific basis for traditional health practices, supporting the discovery of dietary interventions and botanical therapies for metabolic conditions, infections, and lifestyle diseases.

Commercialisation angle

The findings suggest potential commercial applications in functional beverages, herbal dietary supplements, and nutraceutical formulations targeting cholesterol reduction and diabetes management. Relevant commercial users include beverage processors and wellness product developers. Because the abstract reports a review of identified compounds and health properties rather than primary clinical trials or processing data, commercialisation remains at an early stage requiring formal product development and safety testing.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Recently, significant attention has been paid to the biologically active substances in plants that aid in preventing, treating or delaying diseases brought on by inflammatory and oxidative processes. There is scientific evidence to support the use of plant extracts in traditional medicines to treat bacterial, protozoal, and helminthic illnesses. From the leaf of Vernonia amygdalina also, phytochemicals have been identified and extracted, including alkaloids, tannins, steroids, cyanogenic glycosides, flavonoids, phenolic acids, lignans, xanthones, anthraquinones, oxalate and saponins. This article provides a comprehensive overview of the bioactive components of bitter leaf and how they contribute to its medicinal properties. Its health benefits; including its ability to lower cholesterol levels, it's anticancer and antioxidant properties as well it's potential as a natural remedy for diabetes are also discussed. Conclusively, the article underscores the significance of drinking bitter leaf juice and the effects it has on health and wellness.

Research topics

  • Natural Antidiabetic Agents Studies
  • Cassava research and cyanide
  • Psidium guajava Extracts and Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.focha.2023.100488

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.